BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36965231)

  • 1. Synergetic effect of Azacitidine and Sorafenib in treatment of a case of myeloid neoplasm with sole chromosomal abnormality t(8;22)(p11.2;q11.2)/BCR-FGFR1 rearrangement.
    Dhangar S; Shanmukhaiah C; Sawant L; Ghatanatti J; Shah A; Mathan S LP; Vundinti BR
    Cancer Genet; 2023 Jun; 274-275():26-29. PubMed ID: 36965231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review.
    Washburn E; Bayerl MG; Ketterling RP; Malysz J
    Cancer Genet; 2021 Nov; 258-259():69-73. PubMed ID: 34551378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement.
    Wang W; Tang G; Kadia T; Lu X; Li Y; Huang L; Montenegro-Garreaud X; Miranda RN; Wang SA
    J Natl Compr Canc Netw; 2016 Jun; 14(6):708-11. PubMed ID: 27283163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid/lymphoid neoplasms with FGFR1 rearrangement.
    Strati P; Tang G; Duose DY; Mallampati S; Luthra R; Patel KP; Hussaini M; Mirza AS; Komrokji RS; Oh S; Mascarenhas J; Najfeld V; Subbiah V; Kantarjian H; Garcia-Manero G; Verstovsek S; Daver N
    Leuk Lymphoma; 2018 Jul; 59(7):1672-1676. PubMed ID: 29119847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
    Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC
    Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute leukemia showing t(8;22)(p11;q11), myelodysplasia, CD13/CD33/CD19 expression and immunoglobulin heavy chain gene rearrangement.
    Shimanuki M; Sonoki T; Hosoi H; Watanuki J; Murata S; Mushino T; Kuriyama K; Tamura S; Hatanaka K; Hanaoka N; Nakakuma H
    Acta Haematol; 2013; 129(4):238-42. PubMed ID: 23328683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation.
    Peiris MN; Meyer AN; Warda D; Campos AR; Donoghue DJ
    Oncotarget; 2022; 13():659-676. PubMed ID: 35574218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
    Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
    Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2).
    Kim SY; Kim JE; Park S; Kim HK
    Cancer Genet; 2014 Jun; 207(6):258-62. PubMed ID: 25037443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
    Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
    Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
    Salem A; Loghavi S; Tang G; Huh YO; Jabbour EJ; Kantarjian H; Wang W; Hu S; Luthra R; Medeiros LJ; Khoury JD
    Am J Hematol; 2017 Jun; 92(6):520-528. PubMed ID: 28253536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation.
    Chen X; Huang L; Zheng C; Wang Z
    Hematology; 2021 Dec; 26(1):691-696. PubMed ID: 34493159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
    Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/
    Manur R; Sung PJ; Loren AW; Ritchie EK; Frank D; Bagg A; Geyer JT; Bogusz AM
    Leuk Lymphoma; 2020 Feb; 61(2):450-454. PubMed ID: 31524018
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
    Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
    J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p.
    Pini M; Gottardi E; Scaravaglio P; Giugliano E; Libener R; Baraldi A; Muzio A; Cornaglia E; Saglio G; Levis A
    Hematol J; 2002; 3(6):315-6. PubMed ID: 12522455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.